INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
05/11/2026
Back to search
Official data from USPTO
OMLONTI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
05/12/2026
Trademark type
Word
Nice classes
5
Filing date
11/13/2017
Registration date
01/01/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/10/2025
Last transaction
05/12/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Osaka-shi Osaka, JP
Examiner
CORWIN, CHARLOTTE K
Current location
Historical data usage
Holders and representatives
Holders
Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co., Ltd.
Representatives
Danielle K. Munoz Fitch, Even, Tabin & Flannery, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Collyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for the treatment of eye diseases and conditions; pharmaceutical preparations for use in eye injections for the treatment of eye diseases and conditions; pharmaceutical preparations for treatment of pinguecula; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions ; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical use; capsules for medicinescapsules sold empty for pharmaceuticals and drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cottoncotton for medical purposescotton sticks for medical purposes and antiseptic cotton; adhesive plastersadhesive plasters for medical purposessticking plasters for medical purposes and medical and surgical plasters; bandages for dressings; liquid bandagesantiseptic liquid bandagesliquid bandage sprays and liquid bandages for skin wounds; breast-nursing pads; cotton sticks for medical purposes; incontinence diapers; diapers; diaper coversinserts specially adapted for cloth infant diapers made of microfiber and infant diaper covers of textile; dietary supplements for humans; nutritional supplements; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babiesinfant formula and meal replacement beverages for babies adapted for medical use; food for babies; dietary supplements for animals
Publications
History of USPTO decisions and trademark events.
32 publications found
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/10/2025
71AG
REGISTERED-SEC.71 ACCEPTED
09/10/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/08/2025
ES71
TEAS SECTION 71 RECEIVED
06/04/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/01/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/01/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/03/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/17/2019
FIMP
FINAL DISPOSITION PROCESSED
04/17/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/01/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
01/01/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/16/2018
PUBO
PUBLISHED FOR OPPOSITION
10/16/2018
GPNX
NOTIFICATION PROCESSED BY IB
10/12/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/26/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/26/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/26/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/10/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/06/2018
ALIE
ASSIGNED TO LIE
08/30/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/15/2018
RFNP
REFUSAL PROCESSED BY IB
04/06/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/20/2018
RFRR
REFUSAL PROCESSED BY MPU
03/20/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/14/2018
CNRT
NON-FINAL ACTION WRITTEN
03/13/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/10/2018
DOCK
ASSIGNED TO EXAMINER
03/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/06/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/01/2018
Continuous trademark protection
Get notified about every new filing that threatens OMLONTI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.